(PharmaNewsWire.Com, May 20, 2017 ) Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
The effective usage of a CMO Scorecard is basically to enable the CMO industry to scale its performance over time, as well as for CMOs to scale their performance against the industry. The report offers precise data on the 2016 drug approvals authorized by FDAs CBER, CDER, Fast Track and Breakthrough drugs, along with selected EMA approved drugs. Interestingly, this research study for the first time encloses information on the location of outsourced dose manufacturing facilities.
In the initial section of the report, the reader can gain information related to NDA Approvals overview, outsourced dose manufacture and outsourced dose form. For providing in-depth knowledge about this sector, the report also highlights the special product categories. This information is quite beneficial for the strategic decision makers from the CMO industry.
In the later section, buyers can check out details regarding CMO performance as well as Outsourced API approvals, both of which are needed to understand the CMO Scorecard in a better manner. The report also targets the regional divergence, with the availability of segments comprising of U.S. vs EU Approval Performance and manufacture by country. The various pharma companies are also included in the report containing data related to Outsourcing by Global Bio/Pharma Companies.
For the enlightenment of the reader, this intelligent report also covers a list of tables which makes the information crisp and clear-cut. The tables included in the report offers content related to approvals of dosage form, outsourced NDA approvals by dosage form, outsourcing by sponsor type and FDA approval type 2011-2016, dose CMOs receiving approvals in 2016 and AP CMOs receiving approvals in 2016. Apart from tables, the buyer can also access pictorial representation of data with the availability of figures concentrating on information considering NDA approvals 2007-2016, EMA approvals 2012-2016, Breakthrough NME Drug Approvals 2013-2016, Fast Track NME Drug Approvals 2001-2016 etc. This report is an excellent source for CMO executives who seriously follow the global CMO industry, along with Bio/Pharma sponsors who buy contract manufacturing services.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of Pharmaceutical Market Research Reports been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street, Albany, NY 12207, United States Toll Free: 866-997-4948 (US-Canada) Tel: +1-518-621-2074 Email: press@marketresearchhub.com Website: http://www.marketresearchhub.com/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
